Showing results (41-50 of 65) with videos related to
Sort By:
Pageof 7
Journal of Clinical Hypertension (Greenwich, Conn.)|March 11, 2004
Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT studyJoshua I Barzilay, Barry R Davis, Judy Bettencourt, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 5, 2008
Progression of kidney disease in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin versus usual care: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Mahboob Rahman, Charles Baimbridge, Barry R Davis, et al.Clinical Nephrology|July 3, 2013
Pravastatin and cardiovascular outcomes stratified by baseline eGFR in the lipid- lowering component of ALLHATMahboob Rahman, Charles Baimbridge, Barry R Davis, et al.American Journal of Hypertension|April 18, 2009
Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trialBrent M Egan, Jan N Basile, Shakaib U Rehman, et al.Journal of General Internal Medicine|July 9, 2014
Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHATLinda B Piller, Lara M Simpson, Sarah Baraniuk, et al.Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 27, 2024
36-month durability of ultrasound renal denervation for hypertension resistant to combination therapy in RADIANCE-HTN TRIOMichael J Bloch, Ajay J Kirtane, Michel Azizi, et al.Hypertension (Dallas, Tex. : 1979)|August 10, 2016
Orthostatic Hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Blood Pressure Trial: Prevalence, Incidence, and Prognostic SignificanceJerome L Fleg, Gregory W Evans, Karen L Margolis, et al.Hypertension (Dallas, Tex. : 1979)|February 24, 2001
Baseline Characteristics of Participants in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Richard H. Grimm, Karen L. Margolis, Vasilios Papademetriou, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|December 19, 2008
Blood pressure control by drug group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)William C Cushman, Charles E Ford, Paula T Einhorn, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 8, 2021
Changes in blood pressure after crossover to ultrasound renal denervation in patients initially treated with sham in the RADIANCE-HTN SOLO trialFelix Mahfoud, Michael J Bloch, Michel Azizi, et al.Pageof 7